Intriguingly, knocking down EFTUD2 resulted in rapid degradation of c-MYC; however, MG132 treatment effectively reversed this effect, suggesting a pivotal role of EFTUD2 in the UPS-dependent degradation of c-MYC protein in CRC cells (Fig. 6C). The gene discussed is EFTUD2; the disease is colorectal carcinoma.